Identification and characterization of a novel ergothioneine conjugate of raloxifene.

IF 4 3区 医学 Q1 PHARMACOLOGY & PHARMACY Drug Metabolism and Disposition Pub Date : 2025-02-01 Epub Date: 2025-01-09 DOI:10.1016/j.dmd.2024.100034
Abhijith Rao, Sivaprasad Putluru, Prasanth Eapen, Hemantha Kumar, Raviraj Landge, Khemraj Bairwa, Srikanth Sridhar, T Thanga Mariappan, Michael Sinz, Prakash Vachaspati
{"title":"Identification and characterization of a novel ergothioneine conjugate of raloxifene.","authors":"Abhijith Rao, Sivaprasad Putluru, Prasanth Eapen, Hemantha Kumar, Raviraj Landge, Khemraj Bairwa, Srikanth Sridhar, T Thanga Mariappan, Michael Sinz, Prakash Vachaspati","doi":"10.1016/j.dmd.2024.100034","DOIUrl":null,"url":null,"abstract":"<p><p>Raloxifene (RX) in the presence of liver microsomes and glutathione (GSH) has shown oxidative bioactivation to reactive intermediates that are conjugated by GSH. L-Ergothioneine (ET) is a naturally occurring sulfhydryl amino acid, similar to GSH, derived from dietary sources with antioxidant properties and reported to accumulate in high concentrations in animals and humans. We hypothesized that ET may have detoxification/conjugation properties similar to GSH. Using rat and human liver microsomes and mouse, rat, dog, monkey, and human hepatocytes, a novel ergothioneine conjugate of raloxifene (RX-ET) (M1) was identified by mass spectrometry. The RX-ET conjugate was further scaled up in rat liver microsomes, isolated, and characterized by high-resolution mass spectrometry and NMR to confirm the structure. A single RX-ET conjugate was characterized and the site of ET conjugation was identified at the C-17 position of RX. The in vivo relevance of this unique conjugate was also established through metabolism studies in intact and bile duct cannulated rats, both untreated and pretreated with ET. In general, the RX-ET conjugate was found in trace amounts in plasma and urine, but in higher concentrations in bile and feces. The major elimination pathway of RX-ET was through biliary elimination. In rats that were pretreated with ET prior to RX administration, significantly larger quantities of ET and RX-ET conjugate were found in in vivo samples. Lastly, these studies suggest that ET conjugation is an additional pathway for scavenging reactive species arising from xenobiotics and may potentially reduce drug-related toxicities. SIGNIFICANCE STATEMENT: Ergothioneine is well known for its antioxidant and free radical scavenging activity. This study identifies its role in conjugating the reactive species arising from the bioactivation of raloxifene in vitro and in vivo suggesting that ergothioneine may act as an additional conjugation pathway similar to glutathione in the disposition of reactive centers or metabolites of xenobiotics.</p>","PeriodicalId":11309,"journal":{"name":"Drug Metabolism and Disposition","volume":"53 2","pages":"100034"},"PeriodicalIF":4.0000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Metabolism and Disposition","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.dmd.2024.100034","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/9 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Raloxifene (RX) in the presence of liver microsomes and glutathione (GSH) has shown oxidative bioactivation to reactive intermediates that are conjugated by GSH. L-Ergothioneine (ET) is a naturally occurring sulfhydryl amino acid, similar to GSH, derived from dietary sources with antioxidant properties and reported to accumulate in high concentrations in animals and humans. We hypothesized that ET may have detoxification/conjugation properties similar to GSH. Using rat and human liver microsomes and mouse, rat, dog, monkey, and human hepatocytes, a novel ergothioneine conjugate of raloxifene (RX-ET) (M1) was identified by mass spectrometry. The RX-ET conjugate was further scaled up in rat liver microsomes, isolated, and characterized by high-resolution mass spectrometry and NMR to confirm the structure. A single RX-ET conjugate was characterized and the site of ET conjugation was identified at the C-17 position of RX. The in vivo relevance of this unique conjugate was also established through metabolism studies in intact and bile duct cannulated rats, both untreated and pretreated with ET. In general, the RX-ET conjugate was found in trace amounts in plasma and urine, but in higher concentrations in bile and feces. The major elimination pathway of RX-ET was through biliary elimination. In rats that were pretreated with ET prior to RX administration, significantly larger quantities of ET and RX-ET conjugate were found in in vivo samples. Lastly, these studies suggest that ET conjugation is an additional pathway for scavenging reactive species arising from xenobiotics and may potentially reduce drug-related toxicities. SIGNIFICANCE STATEMENT: Ergothioneine is well known for its antioxidant and free radical scavenging activity. This study identifies its role in conjugating the reactive species arising from the bioactivation of raloxifene in vitro and in vivo suggesting that ergothioneine may act as an additional conjugation pathway similar to glutathione in the disposition of reactive centers or metabolites of xenobiotics.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一种新型雷洛昔芬麦角硫因偶联物的鉴定与表征。
雷洛昔芬(RX)在肝微粒体和谷胱甘肽(GSH)存在下显示出氧化生物活性,这些活性中间体由谷胱甘肽偶联。l -麦角硫因(ET)是一种天然存在的巯基氨基酸,类似于谷胱甘肽,从具有抗氧化特性的饮食来源中提取,据报道在动物和人类中积累的浓度很高。我们假设ET可能具有类似谷胱甘肽的解毒/偶联特性。利用大鼠和人肝微粒体以及小鼠、大鼠、狗、猴和人肝细胞,用质谱法鉴定了一种新型雷洛昔芬麦角硫因偶联物(RX-ET) (M1)。RX-ET缀合物在大鼠肝微粒体中进一步放大,分离,并通过高分辨率质谱和核磁共振进行表征以确认其结构。表征了一个单一的RX-ET偶联物,并在RX的C-17位置确定了ET偶联位点。这种独特的缀合物的体内相关性也通过未治疗和预处理的完整大鼠和胆管插管大鼠的代谢研究得到了证实。一般来说,RX-ET缀合物在血浆和尿液中存在微量,但在胆汁和粪便中浓度较高。RX-ET的主要清除途径为胆汁清除。在RX给药前用ET预处理的大鼠中,体内样品中发现了大量的ET和RX-ET缀合物。最后,这些研究表明,ET偶联是清除外源药物产生的活性物质的另一种途径,并可能潜在地减少药物相关的毒性。意义声明:麦角硫因具有抗氧化和清除自由基的活性。本研究确定了麦角硫因在体外和体内偶联雷洛昔芬生物活化引起的活性物质的作用,这表明麦角硫因可能作为一种额外的偶联途径,类似于谷胱甘肽在处理异种生物的活性中心或代谢物方面的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.50
自引率
12.80%
发文量
128
审稿时长
3 months
期刊介绍: An important reference for all pharmacology and toxicology departments, DMD is also a valuable resource for medicinal chemists involved in drug design and biochemists with an interest in drug metabolism, expression of drug metabolizing enzymes, and regulation of drug metabolizing enzyme gene expression. Articles provide experimental results from in vitro and in vivo systems that bring you significant and original information on metabolism and disposition of endogenous and exogenous compounds, including pharmacologic agents and environmental chemicals.
期刊最新文献
Prevalence of non-cytochrome P450-mediated metabolism in food and drug administration-approved drugs: 2005-2024. Lysine- and cysteine-based protein adduction resulting from metabolic activation of fraxinellone in Dictamni Cortex. Mechanism-guided untargeted-to-targeted lipidomics identifies phosphatidylcholine 38:4 in rat bile as an Abcb4/Mdr2 inhibition marker. Lirafugratinib attenuates ABCG2-dependent drug efflux and restores chemosensitivity in multidrug-resistant nonsmall cell lung cancer cells. P-glycoprotein-mediated impairment of doxorubicin clearance in inflammatory bowel disorders: Mechanistic insights from rat studies and whole-body physiologically based pharmacokinetic modeling.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1